Commonwealth Equity Services’s Axsome Therapeutics AXSM Stock Holding History

Commonwealth Equity Services’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$280K	Buy	1,659 +137	+9%	+$23.7K	﹤0.01%	3696
2025 Q4	$278K	Buy	+1,522	New	+$212K	﹤0.01%	3712
2024 Q1	–	Sell	-7,041	Closed	-$560K	–	4026
2023 Q4	$560K	Buy	7,041 +300	+4%	+$20.1K	﹤0.01%	2605
2023 Q3	$471K	Buy	6,741 +1,558	+30%	+$116K	﹤0.01%	2650
2023 Q2	$372K	Buy	+5,183	New	+$382K	﹤0.01%	2856
2023 Q1	–	Sell	-9,624	Closed	-$742K	–	3779
2022 Q4	$742K	Sell	9,624 -576	-6%	-$34.4K	﹤0.01%	2153
2022 Q3	$455K	Sell	10,200 -1,473	-13%	-$73.6K	﹤0.01%	2486
2022 Q2	$447K	Sell	11,673 -1,318	-10%	-$41.7K	﹤0.01%	2489
2022 Q1	$537K	Sell	12,991 -3,993	-24%	-$124K	﹤0.01%	2462
2021 Q4	$641K	Buy	16,984 +2,079	+14%	+$76.5K	﹤0.01%	2323
2021 Q3	$491K	Buy	+14,905	New	+$581K	﹤0.01%	2483

Other funds holding AXSM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Commonwealth Equity Services's AXSM Position: Q1 2026 in Review

Commonwealth Equity Services increased its Axsome Therapeutics (AXSM) stake by 9% in Q1 2026, buying an estimated $23.7K and bringing the position to 1,659 shares worth $280K. The position accounts for ﹤0.01% of the portfolio, ranked #3696.

Commonwealth Equity Services first reported a position in AXSM in Q3 2021 and has held it in 11 quarters since. The position peaked at $742K in Q4 2022. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

Commonwealth Equity Services held 1,659 shares of Axsome Therapeutics worth $280K as of Q1 2026.
Commonwealth Equity Services bought 137 Axsome Therapeutics shares in Q1 2026, an estimated $23.7K.
Axsome Therapeutics made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q1 2026, its #3696 holding.
Commonwealth Equity Services first reported a position in Axsome Therapeutics in Q3 2021 and has held it in 11 quarters since.
Commonwealth Equity Services's Axsome Therapeutics position peaked at $742K in Q4 2022.
409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Commonwealth Equity Services's 13F filing for Q1 2026, filed 27 Apr 2026.